ICUI
Price
$132.61
Change
+$1.25 (+0.95%)
Updated
Jun 5, 12:57 PM (EDT)
Capitalization
2.55B
67 days until earnings call
MYGN
Price
$5.21
Change
-$0.07 (-1.32%)
Updated
Jun 5, 10:32 AM (EDT)
Capitalization
1.93B
56 days until earnings call
Interact to see
Advertisement

ICUI vs MYGN

Header iconICUI vs MYGN Comparison
Open Charts ICUI vs MYGNBanner chart's image
ICU Medical
Price$132.61
Change+$1.25 (+0.95%)
Volume$100
Capitalization2.55B
Myriad Genetics
Price$5.21
Change-$0.07 (-1.32%)
Volume$921
Capitalization1.93B
ICUI vs MYGN Comparison Chart
Loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICUI vs. MYGN commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Hold and MYGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ICUI: $131.36 vs. MYGN: $5.29)
Brand notoriety: ICUI and MYGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICUI: 86% vs. MYGN: 140%
Market capitalization -- ICUI: $2.55B vs. MYGN: $1.93B
ICUI [@Medical Specialties] is valued at $2.55B. MYGN’s [@Medical Specialties] market capitalization is $1.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 1 FA rating(s) are green whileMYGN’s FA Score has 1 green FA rating(s).

  • ICUI’s FA Score: 1 green, 4 red.
  • MYGN’s FA Score: 1 green, 4 red.
According to our system of comparison, ICUI is a better buy in the long-term than MYGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 3 TA indicator(s) are bullish while MYGN’s TA Score has 4 bullish TA indicator(s).

  • ICUI’s TA Score: 3 bullish, 5 bearish.
  • MYGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MYGN is a better buy in the short-term than ICUI.

Price Growth

ICUI (@Medical Specialties) experienced а +2.25% price change this week, while MYGN (@Medical Specialties) price change was +27.47% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.90%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +1.32%.

Reported Earning Dates

ICUI is expected to report earnings on Aug 11, 2025.

MYGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+0.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than MYGN($1.93B). ICUI YTD gains are higher at: -15.344 vs. MYGN (-61.415). ICUI has higher annual earnings (EBITDA): 253M vs. MYGN (-197.4M). ICUI has more cash in the bank: 255M vs. MYGN (141M). MYGN has less debt than ICUI: MYGN (152M) vs ICUI (1.7B). ICUI has higher revenues than MYGN: ICUI (2.26B) vs MYGN (753M).
ICUIMYGNICUI / MYGN
Capitalization2.55B1.93B132%
EBITDA253M-197.4M-128%
Gain YTD-15.344-61.41525%
P/E Ratio333.33N/A-
Revenue2.26B753M300%
Total Cash255M141M181%
Total Debt1.7B152M1,121%
FUNDAMENTALS RATINGS
ICUI vs MYGN: Fundamental Ratings
ICUI
MYGN
OUTLOOK RATING
1..100
105
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9091
PRICE GROWTH RATING
1..100
6197
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (92) in the Medical Specialties industry is in the same range as MYGN (97) in the Biotechnology industry. This means that ICUI’s stock grew similarly to MYGN’s over the last 12 months.

ICUI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MYGN (100) in the Biotechnology industry. This means that ICUI’s stock grew similarly to MYGN’s over the last 12 months.

ICUI's SMR Rating (90) in the Medical Specialties industry is in the same range as MYGN (91) in the Biotechnology industry. This means that ICUI’s stock grew similarly to MYGN’s over the last 12 months.

ICUI's Price Growth Rating (61) in the Medical Specialties industry is somewhat better than the same rating for MYGN (97) in the Biotechnology industry. This means that ICUI’s stock grew somewhat faster than MYGN’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is in the same range as MYGN (2) in the Biotechnology industry. This means that ICUI’s stock grew similarly to MYGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUIMYGN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
67%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 14 days ago
68%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSLEX68.800.36
+0.53%
American Funds SMALLCAP World R4
BOPAX23.97N/A
N/A
Sterling Capital Special Opps A
PPSFX20.35N/A
N/A
Principal Large Cap Value III R3
MDEGX14.50N/A
N/A
BlackRock Unconstrained Equity Inv A
FHERX13.39N/A
N/A
Federated Hermes SDG Engagement Eq R6

MYGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with WAT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
+8.40%
WAT - MYGN
39%
Loosely correlated
+1.08%
ATEC - MYGN
34%
Loosely correlated
-3.00%
VCYT - MYGN
32%
Poorly correlated
+2.98%
ICUI - MYGN
31%
Poorly correlated
+0.63%
AORT - MYGN
31%
Poorly correlated
+0.74%
More